Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.30 is 46% below its 5-year average of 2.42, near the low end of its 5-year range (0.88–8.96).
As of the fiscal period ended Tuesday, June 30, 2026. 12.62% above its 12-month average of 1.15.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.30.
QUICK RATIO (ACID-TEST)
1.30
QUICK RATIO (ACID-TEST) AVG TTM
1.15
QUICK RATIO (ACID-TEST) AVG 3Y
1.33
QUICK RATIO (ACID-TEST) AVG 5Y
2.42
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+12.62%
CURRENT VS 3Y AVG
-2.77%
CURRENT VS 5Y AVG
-46.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 511 covered companies
CURRENT VS SECTOR MEDIAN
-56.67%
vs the sector median at left
Eton Pharmaceuticals, Inc.
Market Cap
$1.53B
Quick Ratio (Acid-Test)
1.30
TTM Avg
1.15
3Y Avg
1.33
5Y Avg
2.42
Market Cap
$1.53B
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.52B
Quick Ratio (Acid-Test)
28.70
TTM Avg
25.68
3Y Avg
28.23
5Y Avg
39.61
Market Cap
$1.54B
Quick Ratio (Acid-Test)
15.18
TTM Avg
8.03
3Y Avg
6.72
5Y Avg
22.81
Market Cap
$1.47B
Quick Ratio (Acid-Test)
2.94
TTM Avg
3.04
3Y Avg
2.84
5Y Avg
2.90
Market Cap
$1.46B
Quick Ratio (Acid-Test)
5.61
TTM Avg
9.29
3Y Avg
11.65
5Y Avg
16.84
Market Cap
$1.44B
Quick Ratio (Acid-Test)
35.85
TTM Avg
18.03
3Y Avg
18.03
5Y Avg
18.03
Market Cap
$1.42B
Quick Ratio (Acid-Test)
11.11
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.53B | 1.30 | 1.15 | 1.33 | 2.42 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.53B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | 28.70 | 25.68 | 28.23 | 39.61 |
| Innoviva, Inc. (INVA)vs › | $1.54B | 15.18 | 8.03 | 6.72 | 22.81 |
| Certara, Inc. (CERT)vs › | $1.56B | 2.55 | 2.09 | 2.53 | 2.95 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 2.94 | 3.04 | 2.84 | 2.90 |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 5.61 | 9.29 | 11.65 | 16.84 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.44B | 35.85 | 18.03 | 18.03 | 18.03 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.42B | 11.11 | 12.01 | 12.01 | 12.01 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | 1.07 | 1.43 | 1.49 | 1.78 |
Quick Ratio
1.30
Excludes inventory
Current Ratio
1.52
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.30 |
| 2026-03-31 | 0.88 |
| 2025-12-31 | 1.17 |
| 2025-09-30 | 1.25 |
| 2025-06-30 | 1.16 |
| 2025-03-31 | 1.43 |
| 2024-12-31 | 1.29 |
| 2024-09-30 | 1.41 |
| 2024-06-30 | 1.28 |
| 2024-03-31 | 1.43 |
| 2023-12-31 | 1.60 |
| 2023-09-30 | 2.51 |
| 2023-06-30 | 2.66 |
| 2023-03-31 | 2.49 |
| 2022-12-31 | 3.01 |
| 2022-09-30 | 3.42 |
| 2022-06-30 | 5.05 |
| 2022-03-31 | 5.24 |
| 2021-12-31 | 5.06 |
| 2021-09-30 | 4.76 |
| 2021-06-30 | 8.96 |
| 2021-03-31 | 9.04 |
| 2020-12-31 | 6.18 |
| 2020-09-30 | 2.51 |
| 2020-06-30 | 4.06 |
| 2020-03-31 | 6.64 |
| 2019-12-31 | 7.45 |
| 2019-09-30 | 10.94 |
| 2019-06-30 | 11.48 |
| 2019-03-31 | 5.89 |
| 2018-12-31 | 13.59 |
| 2018-09-30 | 5.68 |
| 2018-06-30 | 8.08 |
| 2018-03-31 | 11.99 |
| 2017-12-31 | 16.76 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
